Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × trametinib × 30 days × Clear all

Phase

Phase 2 13 Phase 1/2 5 Phase 1 4 Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Melanoma 1

Interventions

Carboplatin 80 pembrolizumab 78 Cisplatin 61 Paclitaxel 59 Specimen Handling 54 Magnetic Resonance Spectroscopy 54 Gemcitabine 48 Docetaxel 40 Dexamethasone 34 Pemetrexed 32 Bevacizumab 31 Radiation 27 Lenalidomide 27 Cyclophosphamide 27 durvalumab 26 Oxaliplatin 26 Nivolumab 26 Doxorubicin 26 Fluorouracil 25 Leucovorin 24 atezolizumab 23 Capecitabine 23 Radiotherapy 22 Rituximab 21 130-nm albumin-bound paclitaxel 21 daratumumab 19 Letrozole 19 Taxes 17 Prednisone 17 Vincristine 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01682083 2026-04-21

COMBI-AD

Novartis

Phase 3 Completed

870 enrolled 15 charts 1 FDA

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡